NuVasive Inc. has announced FDA 510(k) clearance for expanded indication of Attrax putty for use in interbody fusion of the thoracolumbar spine, according to a press release.Attrax putty is a synthetic, biologic and osteoconductive bone void filler, which is designed to perform similar to autograft bone, according to the release.